Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 2
2003 1
2004 4
2005 4
2006 4
2007 3
2008 4
2009 5
2010 6
2011 10
2012 3
2013 6
2014 6
2015 5
2016 1
2017 3
2018 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
[Transglutaminase and neurodegenerative diseases].
Liu Z, Zeng J, Zeng S, Tang B, Wang J. Liu Z, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Aug;32(4):562-6. doi: 10.3760/cma.j.issn.1003-9406.2015.04.025. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015. PMID: 26252108 Review. Chinese.
TGase has been found to contribute to a variety of important physiological and pathological processes and play a role in the pathogenesis of multiple diseases. Notably, neurodegenerative diseases such as Huntington's disease, spinocerebellar ataxia, Alzheimer's
TGase has been found to contribute to a variety of important physiological and pathological processes and play a role in the pathogenesis of …
Transglutaminase 2 and neuroinflammation.
Ientile R, Currò M, Caccamo D. Ientile R, et al. Amino Acids. 2015 Jan;47(1):19-26. doi: 10.1007/s00726-014-1864-2. Epub 2014 Nov 15. Amino Acids. 2015. PMID: 25398223 Review.
Several findings emphasize the possible role of the TG2/NF-kappaB activation pathway in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis. ...
Several findings emphasize the possible role of the TG2/NF-kappaB activation pathway in neurodegenerative diseases, including Alzheimer's
Tissue transglutaminase (TG2) and mitochondrial function and dysfunction.
Lai TS, Lin CJ, Wu YT, Wu CJ. Lai TS, et al. Front Biosci (Landmark Ed). 2017 Mar 1;22(7):1114-1137. doi: 10.2741/4536. Front Biosci (Landmark Ed). 2017. PMID: 28199195 Free article. Review.
One calcium-activated enzyme with demonstrated pathophysiological important in mitochondrial disease is tissue transglutaminase (TG2). TG2 is known as a post-translational modification (PTM) enzyme that is induced by oxidative stress. ...Here, we summarize dysfunctional mi …
One calcium-activated enzyme with demonstrated pathophysiological important in mitochondrial disease is tissue transglutaminase (TG2) …
Transglutaminase is linked to neurodegenerative diseases.
Muma NA. Muma NA. J Neuropathol Exp Neurol. 2007 Apr;66(4):258-63. doi: 10.1097/nen.0b013e31803d3b02. J Neuropathol Exp Neurol. 2007. PMID: 17413316 Review.
Multiple lines of evidence suggest that transglutaminase is involved in neurodegenerative diseases including Alzheimer disease, progressive supranuclear palsy, Huntington disease (HD), and Parkinson disease. ...Further research is needed to determine t …
Multiple lines of evidence suggest that transglutaminase is involved in neurodegenerative diseases including Alzheimer disease, progr …
New insight into transglutaminase 2 and link to neurodegenerative diseases.
Min B, Chung KC. Min B, et al. BMB Rep. 2018 Jan;51(1):5-13. doi: 10.5483/bmbrep.2018.51.1.227. BMB Rep. 2018. PMID: 29187283 Free PMC article. Review.
Formation of toxic protein aggregates is a common feature and mainly contributes to the pathogenesis of neurodegenerative diseases (NDDs), which include amyotrophic lateral sclerosis (ALS), Alzheimer's, Parkinson's, Huntington's, and prion diseases. Th …
Formation of toxic protein aggregates is a common feature and mainly contributes to the pathogenesis of neurodegenerative diseases (NDDs), w …
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Martin A, Giuliano A, Collaro D, De Vivo G, Sedia C, Serretiello E, Gentile V. Martin A, et al. Amino Acids. 2013 Jan;44(1):111-8. doi: 10.1007/s00726-011-1081-1. Epub 2011 Sep 22. Amino Acids. 2013. PMID: 21938398 Review.
Transglutaminase activity has been hypothesized to be involved also in the pathogenetic mechanisms responsible for human neurodegenerative diseases. Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, supranuclear palsy …
Transglutaminase activity has been hypothesized to be involved also in the pathogenetic mechanisms responsible for human neurodegenerative d …
Transglutaminase and diseases of the central nervous system.
Hoffner G, Djian P. Hoffner G, et al. Front Biosci. 2005 Sep 1;10:3078-92. doi: 10.2741/1764. Front Biosci. 2005. PMID: 15970562 Review.
Alzheimer's disease, Parkinson's disease and diseases of expanded polyglutamine are associated with insoluble protein aggregates and neuronal death. ...
Alzheimer's disease, Parkinson's disease and diseases of expanded polyglutamine are associated with insol …
Type 2 transglutaminase in neurodegenerative diseases: the mitochondrial connection.
Malorni W, Farrace MG, Rodolfo C, Piacentini M. Malorni W, et al. Curr Pharm Des. 2008;14(3):278-88. Curr Pharm Des. 2008. PMID: 18220838 Review.
Multiple lines of evidence suggest an involvement of the enzyme in neurodegenerative diseases, such as Huntington's (HD) and Parkinson (PD), and that its inhibition, either via drug treatments or genetic approaches, might be beneficial for the treatment of these syn …
Multiple lines of evidence suggest an involvement of the enzyme in neurodegenerative diseases, such as Huntington's (HD) and Parki
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
Iannaccone M, Titta F, Serretiello E, De Vivo G, Martin A, Gentile V. Iannaccone M, et al. Recent Pat CNS Drug Discov. 2013 Dec;8(3):235-42. doi: 10.2174/1574889808666131128105630. Recent Pat CNS Drug Discov. 2013. PMID: 24286449 Review.
Transglutaminase activity has been suggested to be involved in molecular mechanisms responsible for both physiological or pathological processes. For example, neurodegenerative diseases, such as Alzheimer's Disease, Parkinson's Disease, supranuc …
Transglutaminase activity has been suggested to be involved in molecular mechanisms responsible for both physiological or pathological proce …
Transglutaminase 2 in neurodegenerative disorders.
Ruan Q, Johnson GV. Ruan Q, et al. Front Biosci. 2007 Jan 1;12:891-904. doi: 10.2741/2111. Front Biosci. 2007. PMID: 17127346 Review.
Most importantly, numerous studies have presented data demonstrating that dysregulation of TG2 may contribute to the pathogenesis of many neurodegenerative disorders, including Huntington's disease, Alzheimer's disease, Parkinson's
Most importantly, numerous studies have presented data demonstrating that dysregulation of TG2 may contribute to the pathogenesis of many ne …
58 results